Matches in SemOpenAlex for { <https://semopenalex.org/work/W2326168437> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2326168437 abstract "Introduction: Elevated aldosterone (ALD) is associated with chronic kidney disease (CKD) and cardiovascular (CV) complications. Patiromer, a nonabsorbed potassium (K + )-binding polymer, decreases serum K + (sK + ) and may allow increased use of RAAS inhibitors (RAASi) in patients (pts) with CKD and hyperkalemia (HK). This analysis examined the effect of patiromer on ALD, urinary albumin/creatinine ratio (ACR), and blood pressure (BP) in pts with CKD on RAASi. Methods: OPAL-HK was a 2-part, phase 3 study in 243 CKD pts with sK + 5.1–<6.5 mEq/L on RAASi. Pts received patiromer for 4 wks (Part A); pts with moderate-severe HK at baseline (sK + ≥5.5 mEq/L) and sK + 3.8–<5.1 at Part A wk 4 continued on patiromer (n=55) or switched to placebo (n=52) in the 8-wk withdrawal phase (Part B). RAASi were stable prior to and during Part A. Changes in ALD, ACR, and systolic BP/diastolic BP (SBP/DBP) were analyzed. Results: After 4 wks of patiromer sK + , serum ALD and urine ALD/creatinine decreased, while plasma renin activity (PRA) was unchanged; SBP, DBP, and ACR also declined (Table). Mean±SE changes (ng/dL) in serum ALD from Part A wk 4 to Part B wk 4 and to Part B wk 8 were 4.6±1.6 (p<0.01) and 5.7±1.8 (p<0.01) in the placebo and 0.9±1.0 (p=NS) and 0.2±0.8 (p=NS) in the patiromer groups, respectively. Compared with Part A wk 4, SBP (mm Hg) was further reduced at Part B wk 4 (3.1±2.1, p=NS) and Part B wk 8 (5.4±1.9, p<0.01) with maintained improvement in ACR in patiromer pts. Conclusions: Patiromer reduced both sK + and ALD (independent of PRA) in CKD pts with HK on RAASi. ALD reductions correlated with lower BP and ACR. Reduction in sK + may have lowered ALD possibly improving BP and ACR." @default.
- W2326168437 created "2016-06-24" @default.
- W2326168437 creator A5008833510 @default.
- W2326168437 creator A5012514694 @default.
- W2326168437 creator A5033996338 @default.
- W2326168437 creator A5036786422 @default.
- W2326168437 creator A5039443540 @default.
- W2326168437 creator A5047140893 @default.
- W2326168437 creator A5056005655 @default.
- W2326168437 creator A5070514003 @default.
- W2326168437 creator A5086409547 @default.
- W2326168437 date "2015-09-01" @default.
- W2326168437 modified "2023-09-26" @default.
- W2326168437 title "Abstract P602: Patiromer Decreased Aldosterone, Urine Albumin/Creatinine Ratio, and Blood Pressure in Patients with Chronic Kidney Disease and Hyperkalemia on RAAS Inhibitors: Results from OPAL-HK" @default.
- W2326168437 doi "https://doi.org/10.1161/hyp.66.suppl_1.p602" @default.
- W2326168437 hasPublicationYear "2015" @default.
- W2326168437 type Work @default.
- W2326168437 sameAs 2326168437 @default.
- W2326168437 citedByCount "2" @default.
- W2326168437 countsByYear W23261684372016 @default.
- W2326168437 countsByYear W23261684372017 @default.
- W2326168437 crossrefType "journal-article" @default.
- W2326168437 hasAuthorship W2326168437A5008833510 @default.
- W2326168437 hasAuthorship W2326168437A5012514694 @default.
- W2326168437 hasAuthorship W2326168437A5033996338 @default.
- W2326168437 hasAuthorship W2326168437A5036786422 @default.
- W2326168437 hasAuthorship W2326168437A5039443540 @default.
- W2326168437 hasAuthorship W2326168437A5047140893 @default.
- W2326168437 hasAuthorship W2326168437A5056005655 @default.
- W2326168437 hasAuthorship W2326168437A5070514003 @default.
- W2326168437 hasAuthorship W2326168437A5086409547 @default.
- W2326168437 hasConcept C126322002 @default.
- W2326168437 hasConcept C126894567 @default.
- W2326168437 hasConcept C134018914 @default.
- W2326168437 hasConcept C159641895 @default.
- W2326168437 hasConcept C2778525890 @default.
- W2326168437 hasConcept C2778653478 @default.
- W2326168437 hasConcept C2780091579 @default.
- W2326168437 hasConcept C2780243291 @default.
- W2326168437 hasConcept C2780306776 @default.
- W2326168437 hasConcept C71924100 @default.
- W2326168437 hasConcept C84393581 @default.
- W2326168437 hasConceptScore W2326168437C126322002 @default.
- W2326168437 hasConceptScore W2326168437C126894567 @default.
- W2326168437 hasConceptScore W2326168437C134018914 @default.
- W2326168437 hasConceptScore W2326168437C159641895 @default.
- W2326168437 hasConceptScore W2326168437C2778525890 @default.
- W2326168437 hasConceptScore W2326168437C2778653478 @default.
- W2326168437 hasConceptScore W2326168437C2780091579 @default.
- W2326168437 hasConceptScore W2326168437C2780243291 @default.
- W2326168437 hasConceptScore W2326168437C2780306776 @default.
- W2326168437 hasConceptScore W2326168437C71924100 @default.
- W2326168437 hasConceptScore W2326168437C84393581 @default.
- W2326168437 hasIssue "suppl_1" @default.
- W2326168437 hasLocation W23261684371 @default.
- W2326168437 hasOpenAccess W2326168437 @default.
- W2326168437 hasPrimaryLocation W23261684371 @default.
- W2326168437 hasRelatedWork W2005378862 @default.
- W2326168437 hasRelatedWork W2017346924 @default.
- W2326168437 hasRelatedWork W2096740894 @default.
- W2326168437 hasRelatedWork W2124543160 @default.
- W2326168437 hasRelatedWork W2140445493 @default.
- W2326168437 hasRelatedWork W3011378569 @default.
- W2326168437 hasRelatedWork W3117361317 @default.
- W2326168437 hasRelatedWork W3133946270 @default.
- W2326168437 hasRelatedWork W4234160658 @default.
- W2326168437 hasRelatedWork W4280508227 @default.
- W2326168437 hasVolume "66" @default.
- W2326168437 isParatext "false" @default.
- W2326168437 isRetracted "false" @default.
- W2326168437 magId "2326168437" @default.
- W2326168437 workType "article" @default.